Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
408
Frequently Asked Questions
What is Market Cap of Vir Biotechnology Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Vir Biotechnology Inc market cap is $720.97M.
What is the 52-week high for Vir Biotechnology Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Vir Biotechnology Inc 52 week high is $14.45 as of September 09, 2025.
What is the 52-week low for Vir Biotechnology Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Vir Biotechnology Inc 52 week low is $4.16 as of September 09, 2025.
What is Vir Biotechnology Inc stock price today?
Vir Biotechnology Inc stock price today is $5.24.
What was Vir Biotechnology Inc stock price yesterday?
Vir Biotechnology Inc stock price yesterday was $5.19.
What is the PE ratio of Vir Biotechnology Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Vir Biotechnology Inc’s P/E ratio is -1.29.
What is the Price-to-Book ratio of Vir Biotechnology Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Vir Biotechnology Inc P/B ratio is 0.7608.
What is the 50-day moving average of Vir Biotechnology Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Vir Biotechnology Inc 50-day moving average is $5.09.
How many employess does Vir Biotechnology Inc has?